Abuzzahab, M. Jennifer

A phase 3 randomized clinical trial using a o nce‐weekly glucagon‐like peptide‐1 receptor agonist in adolescents and young adults with hypothalamic obesity

Roth, C. L., Perez, F. A., Whitlock, K. B., Elfers, C., Yanovski, J. A., Shoemaker, A. H., & Abuzzahab, M. J. (2021) · Diabetes, Obesity and Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 87

Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial

Roth, C. L., Scimia, C., Shoemaker, A. H., Gottschalk, M., Miller, J., Yuan, G., Malhotra, S., & Abuzzahab, M. J. (2024) · The Lancet Diabetes & Endocrinology

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 76

Hypothalamic obesity: prologue and promise

Abuzzahab, M. J., Roth, C. L., & Shoemaker, A. H. (2019) · Hormone Research in Paediatrics

Regulation of Appetite and ObesityPituitary Gland Disorders and Treatments

Cited by 71

Predictors of weight‐loss response with glucagon‐like peptide‐1 receptor agonist treatment among adolescents with severe obesity

Nathan, B. M., Rudser, K. D., Abuzzahab, M. J., Fox, C. K., Coombes, B. J., Bomberg, E. M., & Kelly, A. S. (2016) · Clinical Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 39

MRI measures of hypothalamic injury are associated with glucagon‐like peptide‐1 receptor agonist treatment response in people with hypothalamic obesity

Perez, F. A., Elfers, C., Yanovski, J. A., Shoemaker, A. H., Abuzzahab, M. J., & Roth, C. L. (2021) · Diabetes, Obesity and Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 29

Diazoxide choline extended‐release tablet in people with Prader‐Willi syndrome: results from long‐term open‐label study

Miller, J. L., Gevers, E., Bridges, N., Yanovski, J. A., Salehi, P., Obrynba, K. S., Felner, E. I., Bird, L. M., Shoemaker, A. H., Angulo, M., et al. (2024) · Obesity

Genetic Syndromes and ImprintingRegulation of Appetite and Obesity

Cited by 26

OR11-01 Efficacy And Safety Of Setmelanotide In Acquired Hypothalamic Obesity: Results From A Double-blind, Multicenter, Placebo-controlled, Randomized Phase 3 Trial

Phillips, S. A., van Santen, H. M., Hamilton, J. K., Shoemaker, A. H., McCormack, S. E., Abuzzahab, M. J., Wabitsch, M. J. F., Dattani, M. T., Tanaka, T., Scimia, C., et al. (2025) · Journal of the Endocrine Society

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 8